A novel composition of endogenous metabolic modulators improves red blood cell properties in sickle cell disease
Myrthe J. van Dijk(Utrecht University), Minke A.E. Rab(Utrecht University), Titine Ruiter(Utrecht University), Wouter W. van Solinge(Utrecht University), Richard van Wijk(Utrecht University), Judith Jans(University Medical Center Utrecht), Brigitte A. van Oirschot(Utrecht University), Jonathan R.A. de Wilde(Utrecht University), Revati Wani(Axcella Health (United States)), Margaret James Koziel(Massachusetts General Hospital), Eduard J. van Beers(Utrecht University), Jennifer Bos(Utrecht University), Marissa J.M. Traets(Utrecht University)
Cited by 1
Related Papers
Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐Analysis
|Clinical Infectious Diseases|2001|969
The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis
|Blood|2005|366
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study
|Blood|2018|165
Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency
|New England Journal of Medicine|2019|162
Noninvasive Markers of Liver Fibrosis Are Highly Predictive of Liver-Related Death in a Cohort of HCV-Infected Individuals With and Without HIV Infection
|The American Journal of Gastroenterology|2010|145